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Abstract
Norovirus is the commonest cause of acute gastrointestinal disease and is the main aetiological agent of outbreaks of
gastroenteritis, particularly in semi-closed environments. Norovirus infections in England typically peak between December
and March each year. The most commonly detected norovirus strains belong to the genetically diverse genogroup-II
genotype-4 (GII-4) genocluster and in the previous two norovirus winter seasons the majority of GII-4 strains in circulation
worldwide have been genetically similar to the GII-4 strain New Orleans 1805/2009/USA. At the beginning of the 2012/13
season a genetically distinct GII-4 strain (Sydney 2012/NSW0514/2012/AU) was described which emerged worldwide during
the winter of 2012/13. Here we describe the emergence of norovirus strains genetically related to Sydney2012 in England
during the 2012/13 season to replace NewOrleans2009 strains as the most commonly detected variant of GII-4 norovirus in
England. Furthermore, we demonstrate that whilst the emergence of Sydney2012 coincided with an early peak in the
number of norovirus outbreaks, there was not an overall increase in norovirus activity compared to the previous season.
Finally, we show that the Sydney2012 strain is associated with distinct genetic changes compared to the NewOrleans2009
strain, and these changes may have contributed to the emergence of the Sydney2012 strain.
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Introduction
Noroviruses are the commonest cause of acute gastrointestinal
disease in England and Wales [1,2] and is recognised as the main
aetiological agent of outbreaks of infectious intestinal disease (IID).
Outbreaks are associated with semi-closed environments and have
the greatest impact and occur with the highest frequency in
healthcare-associated settings, particularly hospitals and care
homes [3]. Norovirus infections are associated with the winter
months [4], and a typical norovirus season runs September–April,
with a peak in numbers of outbreaks between December and
March each year.
Norovirus is a single genus of the Caliciviridae family of positive-
sense single-stranded RNA viruses. The Norovirus genome is
approximately 7500 nucleotides in length, and is organised as
three open reading frames (ORFs). The 59-ORF (ORF1) encodes
a large polyprotein that undergoes post-translational processing
into the viral non-structural proteins; ORF2 encodes the major
capsid protein, VP1; and ORF3 encodes a small basic protein
(VP2) which is thought to be a minor structural protein.
A number of functional domains have been identified in the
VP1 protein [5]: the shell (S) domain forms the contiguous shell of
the virus, whilst the protruding (P) domain forms the surface-
exposed spike structures on the virus surface. The P domain is
further sub-divided into P1 and P2, and it is the P2 domain that
represents the most surface-exposed area of the virus capsid. The
P2 domain is genetically hypervariable and has been associated
with virus-host interactions including cell attachment via histo-
blood group antigens (HBGAs) and it is also thought to be the site
of neutralising antibody epitopes [6–8].
The Norovirus genus shows high genetic variability, and
classification of the Norovirus genus as five recognised genogroups
(GI-GV) is based on the sequence diversity in the ORF2-encodded
VP1 protein [9]. The majority of human norovirus strains belong
to genogroup I (GI) and genogroup II (GII), and these are further
divided into multiple genotypes/genoclusters [9]. The most
commonly detected norovirus strains belong to the genetically
diverse genogroup-II genotype-4 (GII-4) genocluster. The GII-4
strains are most commonly detected in association with outbreaks
in healthcare settings [10]. Strain replacement events occur
periodically among circulating GII-4 norovirus strains [11–13],
and can coincide with higher than average levels of norovirus
activity. Strain replacement events leading to increased levels of
norovirus activity have been observed in England in the winter
seasons of 2001/02 [14], 2005/06 and 2009/10 [15].
In the previous two norovirus winter seasons (2010/11 & 2011/
12), the majority of GII-4 strains in circulation worldwide have
been genetically similar to the GII-4 strain New Orleans 1805/
2009/USA (Accession Number: GU445325) [16]. At the begin-
ning of the 2012/13 season (September-December 2012), inter-
national public health agencies reported the emergence of a GII-4
strain (Sydney 2012/NSW0514/2012/AU, Accession Number:
JX459908) that is genetically distinct from those previously
detected in circulation [17].
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Here we describe the emergence of norovirus strains genetically
related to JX459908/Sydney 2012/NSW0514/2012/AU (hereaf-
ter referred to as Sydney2012) in England during the 2012/13
season to replace strains genetically similar to GU445325/New
Orleans 1805/2009/USA (hereafter referred to as NewOr-
leans2009) as the most commonly detected GII-4 norovirus
genetic cluster in England. Furthermore, we demonstrate that
the emergence of Sydney2012 was associated with an early peak in
the number of norovirus outbreaks, and that the Sydney2012
strain is associated with distinct genetic changes compared to the
NewOrleans2009 strain.
Materials and Methods
Data Sources
Laboratory surveillance of norovirus in England. In the
period May 2012 to June 2013, 592 faecal samples from 592
norovirus-confirmed outbreaks were referred to the Virus Refer-
ence Department, Public Health England, as part of a sentinel
norovirus strain surveillance programme in England. Referrals
were collated from geographically disparate regions in England.
Briefly, suspected norovirus outbreaks are defined locally if
there are two or more cases in a functional care unit within a
hospital that present: (a) two or more episodes of vomiting of
suspected infectious cause occurring in a 24 hour period; or (b)
two or more loose stools in a 24 hour period; or (c) one or more
episodes of both vomiting and diarrhoea within a 24 hour period.
Laboratory testing would be performed on faecal specimens from
at least two symptomatic patients from the care unit. Where at
least two norovirus-positive laboratory results are obtained, a
single norovirus-positive sample would be referred for strain
characterisation as part of the sentinel norovirus strain surveillance
programme.
The Hospital Norovirus Outbreak Reporting
System. The Hospital Norovirus Outbreak Reporting System
(HNORS; www.hpa-bioinformatics.org.uk/noroOBK/) was in-
troduced in January 2009 by the former Health Protection Agency
in conjunction with the Infection Prevention Society in order to
collect information on the epidemiology of norovirus outbreaks in
hospitals in England. HNORS is a web-based surveillance system
whereby infection control staff based in hospitals are able to enter
summary information on outbreaks of suspected or confirmed
norovirus in hospitals. This standard dataset collects key epidemi-
ological information on each outbreak including dates of first and
last onset, number of patients and staff affected, whether there
were any ward or bay closures and ward type. Monthly counts
(May 2012 to June 2013) of laboratory confirmed outbreak reports
were extracted from HNORS for use in analyses.
Laboratory Techniques
Nucleic acid extraction and reverse transcription. Faecal
samples were prepared as 10% suspensions in a balanced salt
solution (Modified Eagles Medium, Gibco, Life Technologies,
Paisley, UK). Total nucleic acid was extracted from a 200 ml
aliquot of faecal suspension using the QIAxtractor automated
nucleic acid extraction platform (QIAGEN Ltd., Crawley, UK),
VX Reagent & Plasticware kit (QIAGEN). Complementary DNA
(cDNA) was generated by reverse transcription as follows: a 40 ml
aliquot of extracted nucleic acid was heat denatured at 95uC for 5
minutes then quenched on ice. Denatured nucleic acid was mixed
with 30 ml reverse transcription reaction mix, prepared as follows:
40 mM random hexamers (Invitrogen, Paisley, UK), 10 mM Tris,
pH 8.0, 50 mM HCl, 5 mM MgCl2, 1 mM of each dNTP
(Invitrogen), 400 U of MuMLV reverse transcriptase (Invitrogen).
Reverse transcription was performed at 37uC for 1 hour, and the
reaction was terminated by incubation at 95uC for 5 minutes, and
then cooled on ice.
Standard genotyping analysis of norovirus
strains. Outbreak samples were confirmed norovirus-positive
in a genogroup-specific real-time PCR assay as previously
described [18]. Genotypes were determined by partial capsid
(ORF2) sequencing (region C), as previously described [19,20].
Strain characterisation of GII-4 norovirus by analysis of
the P2 domain. The P2 domain of GII-4 norovirus strains was
amplified by polymerase chain reaction (PCR) as previously
described [11,21]. Full-length P2 domain amplicons were
sequenced using a dideoxy chain-terminator method, and
sequence analysis was performed using Bionumerics v6.1 (Applied
Maths, Kortijk,Belgium) and MEGA version 5 [22]. Amino acid
sequences were deduced from nucleotide. Throughout, amino acid
motifs are designated here by standard IUPAC single-letter amino
acid code.
Modelling
Homology modelling of GII-4 norovirus P2 domain
sequences. Amino acid residues were localised on the crystal
structure of GII-4 norovirus VA387 [6] using NOC 3.1 software
(http://noch.sourceforge.net/).
Statistical modelling of laboratory and HNORS data. A
quasi-Poisson regression generalised linear model (GLM) was
fitted to estimate the number of HNORS outbreak reports that
could be attributed to Sydney2012. Quasi-Poisson regression is an
adaptation of Poisson regression appropriate for use in the analysis
of count data as it adjusts for over-dispersion of the data, where
variance is greater than the mean. The model included an
intercept in addition to the regression variables; this would provide
a constant term to account for genogroups not explained by the
variation in laboratory reporting. As norovirus is a seasonal
pathogen, we included a dummy variable (winter) to account for
increased number of outbreaks in wintertime.
In the initial full model, monthly HNORS reports were
modelled as a function of strain-typed laboratory data and
included all strain types plus the constant term and the winter
dummy variable. Variables were removed if they were not
significant in the model (p.0.05) or if the coefficient was negative
(because this would imply negative outbreaks which is not logical).
The estimated number of outbreaks attributed to Sydney2012 was
calculated by multiplying the exponent of the coefficient for
Sydney2012 by the number of outbreaks from HNORS. Models
were fitted using R statistical software (R Core Team. R: A
language and environment for statistical computing. R Foundation
for Statistical Computing, Vienna, Austria 2012. http://www.R-
project.org/).
Results
Outbreak reporting of norovirus-associated
gastroenteritis in 2012/13 was associated with a shift in
seasonality, but not an increase in number of outbreaks
In the early part of the 2012/13 norovirus season, between July
and December 2012 (weeks 27 2012 to 52 2012) there were 480
laboratory-confirmed outbreaks reported to HNORS. This
activity was 85% higher than during the same time period in
2011 (Figure 1). HNORS reports began to decline from week 50
2012, around four to eight weeks earlier than in previous seasons
and the overall number of outbreaks reported to HNORS in the
2012/13 season (week 27 2012 to week 26 2013) was 9% lower
than the 2011/12 season.
Emergence of Sydney2012 in England
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Laboratory surveillance shows strains genetically similar
to Sydney2012 were the most frequently detected in
England throughout the 2012/13 season
A total of 592 norovirus-confirmed outbreaks occurring in
England between May 2012 and June 2013 (weeks 21 2012 to 26
2013). We included outbreaks from May and June 2012 in the
laboratory analysis to determine which norovirus strains were most
associated with outbreaks at the end of the 2011/12 season, and
leading into the 2012/13 season. The majority of these outbreaks
(65.4%, n = 387/592) occurred in healthcare-associated settings,
and the most frequently detected norovirus genotype was GII-4
(82%, 485/592) (Table 1), consistent with previous norovirus
seasons.
Following the description of the emerging GII-4 strain
Sydney2012 in December 2012 [17], the diversity among
circulating GII-4 norovirus genotypes was further characterised
by analysis of the hypervariable P2 domain of the capsid-encoding
ORF2. To validate our analysis, 60 GII-4 norovirus-confirmed
outbreaks were chosen at random from week 21 2012 to week 11
2013 of the 2012/13 season, and deduced amino acid sequences
were phylogenetically compared with reference strains represent-
ing historic epidemiologically significant GII-4 genetic variants.
Phylogenetic reconstruction using a neighbour-joining method
indicated two distinct populations of GII-4 genetic variant
norovirus in circulation in England during the 2012/13 season:
one genetically similar to the NewOrleans2009 strain, and a
second genetically similar to the Sydney2012 strain (Figure 2).
Using this method, we designated strain types for GII-4 norovirus
strains detected during the 2012/2013 season (n = 485). The
majority of GII-4 strains were phylogenetically similar to the
Sydney2012 strain (68.9%, n = 334/485), whilst 27.8% (n = 135/
485) were genetically similar to the NewOrleans2009 strain
(Table 1).
A seasonality shift in 2012/13 was associated with the
emergence of the Sydney2012 strain
The seasonal distribution of outbreaks was determined for
outbreaks that met the following criteria: (i) were associated with a
GII-4 norovirus strain, (ii) had been strain typed by analysis of the
hypervariable P2 domain, and (iii) for which a date of outbreak
had been recorded. A total of 328 outbreaks for which the date of
outbreak was provided were included in this analysis: 107
outbreaks associated with NewOrleans2009 and 221 outbreaks
associated with Sydney 2012.
This data showed that the peak of outbreaks occurred between
week 46 2012 and week 52 2012 (November-December 2012)
(Figure 3). Prior to week 46 2012, the majority of outbreaks were
associated with NewOrleans2009 (48/76, 63.2% vs 28/76,
36.8%); whereas, after week 46 2012, the majority of outbreaks
were associated with Sydney2012 (193/252, 76.6% vs 59/252,
23.4%) (Figure 3).
Modelling the contribution of norovirus strains to HNORS
outbreak reports in the 2012/13 season indicates an
association between Sydney2012 emergence and a shift
in seasonality
Table 2 shows the comparison between the final and the initial
full model. Sydney2012 was the only strain significantly associated
Figure 1. Comparison of the average number of weekly reports from HNORS for the 2009-12 seasons versus 2012/13 season in
England. The solid black line indicates number of HNORS laboratory confirmed reports received in the 2012/13 season. The dashed black line
indicates average number of HNORS laboratory confirmed reports received across the 2009/10 to 2011/12 seasons. The solid grey line indicates the
number of HNORS laboratory confirmed reports received in the 2011/12 season.
doi:10.1371/journal.pone.0088978.g001
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with monthly counts of HNORS laboratory confirmed outbreaks
(p,0.001). Although winter was not statistically significant
(p = 0.06), the model comparisons (comparison of residual
deviance) suggested that including the winter term provided a
better fitting model. All other variables (strain types) were removed
from the model. Observed HNORS outbreaks began to increase
from September 2012, with the peak in reports observed in
December 2012. The predicted contribution of Sydney2012 to
HNORS outbreak reports increased from October 2012 and
accounted for the majority of outbreak reports to HNORS after
November 2012. By May 2013 the model suggests that
Sydney2012 had declined in importance (Figure 4).
Sydney2012 is associated with distinct genetic changes
in the hypervariable P2 domain
A multiple alignment (CLUSTALW) of deduced amino acid P2
domain sequences of NewOrleans2009 and Sydney2012 strains
detected during the 2012/13 season was used to compare putative
phenotypic differences between these two strains.
Amino acid motifs (designated by standard IUPAC single-letter
amino acid codes) at two previously identified surface-exposed
sites, site A (residues 296–298) and site B (residues 393–395) [11],
were compared. The most commonly detected motif at site A was
SRN in both NewOrleans2009 and Sydney2012 strains (96.2%
and 90.1%, respectively). The most commonly detected motif at
site B was STT among both NewOrleans2009 and Sydney2012
strains (90.1% and 93.3%, respectively).
Six amino acid positions (294, 310, 359, 368, 373 and 396) were
identified from the multiple alignment that were consistently
associated with Sydney2012 only (Figure 5 & Table 3). Homology
modelling reveals positions 294, 368 and 373 are surface-exposed
and localise around site A; and position 396 is a surface-exposed
residue localised around site B (Figure 5).
Discussion
The periodic emergence of genetically distinct GII-4 norovirus
strains has been well documented [12,13,15]. The biological and
epidemiological success of these strains is, at least in part,
influenced by the fixation of mutations in the hypervariable P2
domain that affect the antigenic profile of the virus [23–25], which
can lead to worldwide strain replacement events [26].
Following the description of the emergence of a novel GII-4
genetic strain (Sydney2012) in late 2012 [17], we followed the
molecular epidemiology of this strain in England, during the
2012/13 norovirus season. Our data indicates that despite an early
start to the 2012/13 norovirus season, norovirus reports also
began to decline earlier than previously observed. Overall, the
number of reported outbreaks to HNORS in the 2012/13 season
was 9% lower than the number reported in the 2011/12 season
and 9% lower than the average of the preceding three seasons.
This suggests that the 2012/13 norovirus season was not
associated with higher than usual activity and therefore, the
emergence of Sydney2012 does not appear to have led to an
increased number of outbreaks reported to HNORS in the 2012/
13 season.
Using a quasi-Poisson regression generalised linear model, we
modelled norovirus outbreak reports and strain-typing laboratory
data from England-based surveillance systems. The objective of
using the GL model was to use laboratory data (in which details of
outbreaks are relatively unknown) and epidemiological data (in
which strain types are unknown) in order to provide an estimate of
the importance of different strains in causing outbreaks. The
model suggests that Sydney2012 accounted for the majority of
observed outbreaks from November 2012 to April 2013. However,
whilst the emergence of Sydney2012 appears to have resulted in
an early start to the 2012/13 season, it does not appear to have
caused an excess number of norovirus reports in comparison to
previous seasons. There are limitations to this study. The
Table 1. Distribution of norovirus strains (by genotype) in England during the 2012/13 season.
Setting
Total
Outbreaks
Hospital/Care
Home Community
Foodborne/
Restaurant
Hotel/Holiday
Resort Cruise Ship Other Data Not Supplied
GI-3 12 (2.0) 6 (1) 4 (0.7) (0) (0) (0) (0) 2 (0.3)
GI-4 13 (2.2) 3 (0.5) 2 (0.3) (0) 1 (0.2) (0) (0) 7 (1.2)
GI-6 9 (1.5) 2 (0.3) 2 (0.3) (0) (0) (0) (0) 5 (0.8)
GI-7 5 (0.8) (0) 1 (0.2) (0) (0) (0) (0) 4 (0.7)
GI-SaitamaT35a 8 (1.4) 2 (0.3) 1 (0.2) (0) (0) (0) (0) 5 (0.8)
GII-1 15 (2.5) 8 (1.4) (0) 1 (0.2) (0) (0) (0) 6 (1)
GII-2 2 (0.3) (0) (0) (0) (0) (0) (0) 2 (0.3)
GII-3 16 (2.7) 9 (1.5) 3 (0.5) (0) (0) (0) (0) 4 (0.7)
GII-4/New Orleans 135 (22.8) 91 (15.4) 3 (0.5) (0) (0) 2 (0.3) 1 (0.2) 38 (6.4)
GII-4/Sydney2012 334 (56.4) 246 (41.6) 16 (2.7) 1 (0.2) 3 (0.5) 1 (0.2) (0) 67 (11.3)
GII-4/Untyped 16 (2.7) 10 (1.7) (0) (0) (0) (0) (0) 6 (1)
GII-5 2 (0.3) 1 (0.2) (0) (0) (0) (0) (0) 1 (0.2)
GII-6 4 (0.7) (0) (0) 1 (0.2) (0) (0) (0) 3 (0.5)
GII-7 18 (3.0) 9 (1.5) (0) (0) (0) (0) (0) 9 (1.5)
GII-ut 3 (0.5) (0) 1 (0.2) (0) (0) (0) (0) 2 (0.3)
Total 592 387 (65.4) 33 (5.6) 3 (0.5) 4 (0.7) 3 (0.5) 1 (0.2) 161 (27.2)
(##) Per cent of all norovirus-confirmed outbreaks (n= 592).
doi:10.1371/journal.pone.0088978.t001
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laboratory data used in the modelling was restricted to 50% of the
total samples received, which could have affected the seasonal
distribution of the laboratory data. Of the samples excluded,
25.1% of samples had no information on the date of the outbreak,
17.5% were negative or could not be typed, and 7.3% of samples
had no information on the date of the outbreak and were negative
or could not be typed. Furthermore, if these laboratory data were
more likely to have included non Sydney2012 strains, the
importance of Sydney2012 would be overestimated in our
modelling. Likewise, if these data were more likely to have
included Sydney2012, its importance would have been underes-
timated in the modelling. Despite these limitations there is still a
considerable amount of data in comparison to other studies
looking at the effect of strain type and norovirus seasonality.
Laboratory strain typing data from the 2012/13 season
presented here indicates that the Sydney2012 strain could be
detected as early as June 2012 (Figure 3). It is noteworthy that in
week 34 2012, the Sydney2012 strain was associated with 100% of
Figure 2. Neighbour-joining tree of 60 GII-4 norovirus P2 domain amino acid sequences detected during the 2012–2013 norovirus
season in England. Red branches indicate the Sydney2012-like strains (reference strain JX459908 highlighted in red text), and blue branches
indicate New Orleans 2009-like strains (reference strain GU445325 highlighted in blue text). Black branches show other epidemiologically significant
GII-4 norovirus reference strains. Branches marked * have bootstrap values $97% after 1000 replicates. Strains sequenced as part of this study are
labelled at the nodes as [Strain Type|OutbreakID|Date of Outbreak (YYYY-WW)].
doi:10.1371/journal.pone.0088978.g002
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outbreaks, whilst in the weeks immediately before and after this, all
outbreaks were associated with NewOrleans2009 (Figure 3), there
was only one outbreak referred in week 34 2012. Furthermore, re-
analysis of historic strains collected in England as part of a national
strain surveillance programme indicates that the Sydney2012
strain was circulating in England as early as 2010 (Figure S1). This
indicates that there was a long lag period between the first
emergence and the first detection and characterisation of the
Sydney2012 strain. In this period transmission networks became
established through which Sydney2012 became widely dissemi-
nated internationally before its identification in 2012 [17].
Although the emergence of Sydney2012 was not associated with
an increase in the number of outbreaks compared to previous
seasons, a strain replacement event occurred in England during
the 2012/13 norovirus season, in which the Sydney2012 strain
replaced NewOrleans2009 to become the most frequently detected
GII-4 norovirus strain in circulation. This suggested that the
Sydney2012 strain has a biological advantage, or increased ‘fitness’
compared to the NewOrleans2009 strain. To investigate this
further, we compared deduced amino acid data for the hyper-
variable P2 domain from GII-4 strains circulating during the
2012/13 season.
Previously, we have characterised two antigenic sites in the P2
domain that are associated with defining the antigenic profile of
the virus [11,24]. These sites (site A, positions 296–298, and site B,
positions 393–395) have also been identified independently by
others and shown to be significant in defining HBGA-binding and
antibody blockade responses [8,27]. Furthermore, we have shown
that the predicted phenotypic changes associated with amino acid
variation at these positions suggests that site A is a major epitope
on the virus surface, responsible for defining the antigenic profile,
whereas site B is associated with minor antigenic variation within
the virus population [15].
Data from this study suggests there were no amino acid changes
at these 6 positions between Sydney2012 and NewOrleans2009
strains. The previously frequently detected site A and site B motifs
SRN and STT, respectively [15], were detected with high
frequency among both NewOrleans2009 and Sydney2012 strains.
Conservation of amino acid residues between NewOrleans2009
and Sydney2012 strains at positions 296–298 and 393–395, in
part, explains why the emergence of Sydney2012 did not result in
a significant increase in the number of norovirus-associated
gastroenteritis outbreaks in the 2012/13 season.
The NewOrleans2009 strains have been the most frequently
detected norovirus strains in England since 2009, and the site A/
site B motif combination SRN/STT has been the most commonly
detected among circulating strains in England since 2009 [15].
This means the majority of the population would have had recent
immunological exposure to these epitopes. The conservation of
these sites in Sydney2012 means the population was not entirely
immunologically naı¨ve to the Sydney2012 strain during the winter
of 2012/13, and the existing immunity in the population may have
been sufficient to mitigate the impact of the emergence of
Sydney2012 in England.
However, Sydney2012 replaced NewOrleans2009 as the most
commonly detected norovirus strain in England by November
2012; this suggests the Sydney2012 strain has a selective advantage
compared to the NewOrleans2009 strains. This may be explained
by amino acid changes associated specifically with the Sydney2012
strain that were detected at 6 other positions in the P2 domain
Figure 3. Detection of NewOrleans2009 and Sydney2012 strains associated with outbreaks (by week) in England during the 2012/
13 norovirus season. Blue bars indicate outbreaks associated with NewOrleans2009. Red bars indicate outbreaks associated with Sydney2012. This
figure shows data for 328 norovirus-confirmed outbreaks where GII-4 strains were associated with the outbreak, P2 domain strain typing data could
be generated, and a date of outbreak was supplied.
doi:10.1371/journal.pone.0088978.g003
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(294, 310, 359, 368, 373 and 396). Positions 294, 368 and 373 are
surface-exposed residues localised around the antigenic site A [11],
(also identified as part of epitope A by Debbink et al, which itself
overlaps with site A [8]) (Figure 5). These changes contribute to
creating antigenic variation that is sufficient to increase the ‘fitness’
of Sydney2012 sufficiently for it to replace the NewOrleans2009
strain among circulating GII-4 norovirus strains, but are not
sufficient to allow the virus to entirely evade existing immunity in
the population without concomitant amino acid changes at sites
296–298 (and to a lesser extent 393–395). This is highlighted in a
recent study by Debbink et al (2013), who also found no amino
acid changes between Sydney2012 and NewOrleans2009 at
positions 296–298 or 393–395, and in agreement with our data
found amino acid changes at residues 294 and 368 (and 372) to be
associated with the Sydney2012 strain [7]. In their paper, Debbink
et al (2013) present experimental data which demonstrates that
Sydney2012 is antigenically different to NewOrleans2009, and
conclude that this observation is effected by amino acid changes
among these residues within epitope A.
However, whilst Debbink et al (2013) demonstrate antigenic
variation between Sydney2012 and NewOrleans2009 [7], surveil-
lance and epidemiological modelling data presented here do not
indicate an overall increase in the number of outbreaks in England
during the last season, which would be expected following the
emergence of a putative antibody escape mutant.
Together, these findings reflect the complexity in understanding
immunity to this virus, and the role antibody-escape plays in the
emergence of novel strains. The reduction in blockade of
Sydney2012 compared to NewOrleans2009 by a monoclonal
antibody described by Debbink et al (2013) demonstrates the
phenotypic impact of amino acid changes in the P2 domain on the
antigenic profile of the virus. However, studies using monoclonal
antibodies are highly specific and do not necessarily reflect the
complex polyclonal response to a natural infection.
This highlights the need for methods that allow a more rapid
understanding of the phenotype of emerging genetic variants, and
in particular for norovirus, the development of tools with which to
interrogate the genotype-to-phenotype mapping of mutations in
the virus genome. Obtaining such information is important in
order to predict the likely impact of an emerging virus strain on
public health. Work on influenza A virus has shown that
laboratory methods which measure phenotypic differences be-
Table 2. Regression model results for outbreaks and
norovirus strain types in England, May 2012 to June 2013.
Initial full model Final model
Strain Coefficient p value Coefficient p value
Sydney2012 0.052 0.03 0.037 ,0.001
Other GII.4 0.118 0.36 -
New Orleans 0.002 0.94 -
Others 20.065 0.14 -
Winter 0.532 0.35 0.853 0.06
doi:10.1371/journal.pone.0088978.t002
Figure 4. Predicted number of HNORS laboratory confirmed outbreaks associated with the Sydney2012 strain by month (May
2012–June 2013) in England. Grey bars (baseline) include all other strain types, which varies according to winter and summer as norovirus is a
seasonal pathogen. Red bars indicate predicted number of HNORS outbreaks associated with Sydney2012. The black line shows the number of
observed laboratory confirmed HNORS outbreaks.
doi:10.1371/journal.pone.0088978.g004
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tween known genetic variants can be used to map the evolution
and emergence of this important human pathogen by both
genotype and phenotype [28].
Understanding the phenotypic impact of amino acid changes in
the norovirus capsid is challenging. Data collected on the
emergence of Sydney2012 suggests variation at positions 294,
368 and 372 and/or 373 is capable of altering the virus’phenotype,
as shown in experimental work by Debbink et al (2013), and may
be sufficient to induce enough ‘fitness’ change to give the
Sydney2012 a selective advantage (if not complete immunological
escape), as demonstrated by the strain replacement event observed
worldwide during the 2012/13 season. Continued surveillance and
integrated epidemiological and laboratory investigation of out-
breaks and characterisation of historic and emerging strains will
help improve our understanding of the dynamics of emerging
norovirus strains.
Supporting Information
Figure S1 Neighbour-joining tree of GII-4 norovirus P2
domain amino acid sequences shows Sydney2012 was
circulating in 2010, 2011, 2012 and 2013. Sequences
highlighted in red are from 2010 and 2011, indicating that the
Sydney2012 strain was circulating in England as early as 2010.
Strains sequenced as part of this study are labelled at the nodes as
[Strain Type|OutbreakID|Date of Outbreak (YYYY-WW)].
Methods and reference strains are the same as Figure 2.
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